spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

ACHEMA 2018

11-15 June 2018
Messe Frankfurt GmbH

New at ACHEMA 2018: focus on chemical and pharma logistics

ACHEMA is the world forum for the process industries, but also an integral part of the trade show calendar of companies specializing in pharma packaging. Every three years 3,800 exhibitors and 170,000 visitors gather in Frankfurt/Main, Germany for the trade show that features everything you need to furnish a chemical or pharma production plant.

Due to the high demand there will be an additional 4.000 m˛ hall for the exhibition group pharmaceutical, packaging and storing techniques in 2018. This hall will also be the home of the Logistics Hotspot, the epicenter of the focal topic Chemical and Pharma Logistics. This special exhibition zone is dedicated to logistics companies specializing in chemical and pharma logistics and covers the whole supply chain from

  • warehousing
  • intralogistics
  • tracking and tracing
  • temperature controlled transport to
  • intermodal transport

The focal topic chemical and pharma logistics comes into play where the logistics become special because chemicals and pharmaceuticals are special products. It starts with temperature sensitive goods and doesn’t stop at hazardous materials.

Intralogistics within a factory are the responsibility of the company, but inbound and outbound transport is increasingly delegated to service providers. These are more and more becoming system partners as digitization leads to changes in supply change management and distribution, too. Many links of this value chain are not yet present at ACHEMA, although they are a logical continuation of packaging topics, a classic at ACHEMA. The Logistics Hotspot opens up this new topic; embedded in the exhibition there is a presentation stage where talks about the latest developments in logistics will be held throughout the week.

 
Print this page
Send to a friend
   
spacer
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>


News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement